Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?
Idiopathic pulmonary fibrosis (IPF) identifies a specific entity characterized by chronic, progressive fibrosing interstitial pneumonia of unknown cause, still lacking effective therapies. Growing evidence suggests that the biologic processes occurring in IPF recall those which orchestrate cancer on...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/6/2882 |
id |
doaj-078f9e1404f24341bef1198fefe972b2 |
---|---|
record_format |
Article |
spelling |
doaj-078f9e1404f24341bef1198fefe972b22021-03-13T00:03:27ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01222882288210.3390/ijms22062882Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?Sara Lettieri0Tiberio Oggionni1Andrea Lancia2Chandra Bortolotto3Giulia Maria Stella4Department of Medical Sciences and Infective Diseases, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, Viale Camillo Golgi, 19, 27100 Pavia, ItalyDepartment of Medical Sciences and Infective Diseases, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, Viale Camillo Golgi, 19, 27100 Pavia, ItalyDepartment of Medical Sciences and Infective Diseases Radiation Therapy Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi, 19, 27100 Pavia, ItalyDepartment of Intensive Medicine, Unit of Radiology, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, Viale Camillo Golgi, 19, 27100 Pavia, ItalyDepartment of Medical Sciences and Infective Diseases, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, Viale Camillo Golgi, 19, 27100 Pavia, ItalyIdiopathic pulmonary fibrosis (IPF) identifies a specific entity characterized by chronic, progressive fibrosing interstitial pneumonia of unknown cause, still lacking effective therapies. Growing evidence suggests that the biologic processes occurring in IPF recall those which orchestrate cancer onset and progression and these findings have already been exploited for therapeutic purposes. Notably, the incidence of lung cancer in patients already affected by IPF is significantly higher than expected. Recent advances in the knowledge of the cancer immune microenvironment have allowed a paradigm shift in cancer therapy. From this perspective, recent experimental reports suggest a rationale for immune checkpoint inhibition in IPF. Here, we recapitulate the most recent knowledge on lung cancer immune stroma and how it can be translated into the IPF context, with both diagnostic and therapeutic implications.https://www.mdpi.com/1422-0067/22/6/2882fibrosiscancerimmune systemmicroenvironmentgeneticstargeted therapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sara Lettieri Tiberio Oggionni Andrea Lancia Chandra Bortolotto Giulia Maria Stella |
spellingShingle |
Sara Lettieri Tiberio Oggionni Andrea Lancia Chandra Bortolotto Giulia Maria Stella Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape? International Journal of Molecular Sciences fibrosis cancer immune system microenvironment genetics targeted therapy |
author_facet |
Sara Lettieri Tiberio Oggionni Andrea Lancia Chandra Bortolotto Giulia Maria Stella |
author_sort |
Sara Lettieri |
title |
Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape? |
title_short |
Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape? |
title_full |
Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape? |
title_fullStr |
Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape? |
title_full_unstemmed |
Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape? |
title_sort |
immune stroma in lung cancer and idiopathic pulmonary fibrosis: a common biologic landscape? |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-03-01 |
description |
Idiopathic pulmonary fibrosis (IPF) identifies a specific entity characterized by chronic, progressive fibrosing interstitial pneumonia of unknown cause, still lacking effective therapies. Growing evidence suggests that the biologic processes occurring in IPF recall those which orchestrate cancer onset and progression and these findings have already been exploited for therapeutic purposes. Notably, the incidence of lung cancer in patients already affected by IPF is significantly higher than expected. Recent advances in the knowledge of the cancer immune microenvironment have allowed a paradigm shift in cancer therapy. From this perspective, recent experimental reports suggest a rationale for immune checkpoint inhibition in IPF. Here, we recapitulate the most recent knowledge on lung cancer immune stroma and how it can be translated into the IPF context, with both diagnostic and therapeutic implications. |
topic |
fibrosis cancer immune system microenvironment genetics targeted therapy |
url |
https://www.mdpi.com/1422-0067/22/6/2882 |
work_keys_str_mv |
AT saralettieri immunestromainlungcancerandidiopathicpulmonaryfibrosisacommonbiologiclandscape AT tiberiooggionni immunestromainlungcancerandidiopathicpulmonaryfibrosisacommonbiologiclandscape AT andrealancia immunestromainlungcancerandidiopathicpulmonaryfibrosisacommonbiologiclandscape AT chandrabortolotto immunestromainlungcancerandidiopathicpulmonaryfibrosisacommonbiologiclandscape AT giuliamariastella immunestromainlungcancerandidiopathicpulmonaryfibrosisacommonbiologiclandscape |
_version_ |
1724222516260503552 |